Diabetes and Impaired glucose tolerance Flashcards

(47 cards)

1
Q

When is a diagnosis of diabetes made?

A

Fasting glucose >7mmol/L

Two hour plasma glucose OR Random plasma glucose >11.1 mmol/L

HbA1c >48 mmol/mol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What two criteria have to both be met for diagnosis of impaired glucose tolerance?

A

Fasting plasma glucose < 7 mmol/L
AND
>7.8 but <11.1 two hour plasma glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Impaired fasting glucose when can diagnose

A

If first or both of following criteria are met
Fasting plasma glucose between 6.1-6.9
AND (if measured
<7.8 two hour plasma glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What HbA2c is prediabetes / IFG or IGT

A

42-47

Fasting glucose 6.1-6.9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the target for HbA1c if diabetes is being managed with any drug that may cause hypoglycaemia eg sulfonylurea?

A

53 mmol/mol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Autoantiboides in T1DM

A

Glutamic acid decarboxylase (GAD 65)
Islet cells (not specific or sensitive)
insulin
Tyrosine phosphatase (IA2 +IA2B)
Zinc transporter (ZnT8)
>80% + for GAD, IA2 or AnT8 n

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

% of T1DM with HLA

A

90% DR3 or DR4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Type 1 vs type 2 diabetes genes

A

type 1 - HLA
tyoe 2 - TCF7L2
May deevlop insulin resitance but may not

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the most powerful genes in terms of causing T2DM

A

tcf7l2
polygenic (50 genes w small effects)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Secondary diabetes mellitus

A

Pancreatic disease and pancreatitis
Cystic fibrosis
Haemochromatosis (iron deposition)
Drug induced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Types of diabetes

A

1 and 2
Secondary
Monogenic
Congenital and neonatal
Syndromic
Chromosomal - increased risk
Mitochondiral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Syndromic diabetes causes

A

Lipodystrophies, prader-willi syndrome, myotonic dystrophy, wolfram (DIDMOAD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Features of mitochondrial disease causing T1DM

A

Deafness and cardio-neural problems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What drugs can cause diabetes

A

Chronic steroid use

Calcineurin inhibitors

Statins

Major antipsychotic agents

HAART

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ass endocrinopathies with diabetes and the hormone in excess that causes that in each

A

Cushings including iatrogenic - glucocorticoids
Acromegaly - growth hormones
Phaeochromocytoma - catecholamines
Glucagonomas
Somatostatinomas
Hyperthyroidism - autoimmune link w type 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What drugs to offer when patient symptomatically hyperglycaemic

A

Insulin or sulonylurea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What do you use if metformin standard release is not tolerated?

A

Metformin modified release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Alternatives to metformin

A

DPP4 inhbitor
Pioglitzone
Sulgoylurea
SGLT2 inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When to consider insulin based treatemnet

A

After triple therapy with metformin
After dual therapy if metformin not tolerated
Combinations:
Metformin + DPP4i + sulfonylurea
M +pioglitazone + sulfonylurea
M +pioglitazone/sulfonylurea + SGLT2i

17
Q

When consider metformin + sulfonylurea + GLP-1 agonist if

A

Triple therapy ineffective, contraindicated OR
BMI >35 in europeans who have comorbidites ass
BMI < 35 w significant occupational implications or weight loss would beneift other comorbidities

18
Q

Treatment lines of HbA1c

A

<48
<58 - increase medication from dual to triple therapy

19
Q

What to do if o triple therapy weight decline >3% and HbA1c >3% in 6 months

A

Continue with only GLP-1 analogue

20
Q

What does insulin based treatment consist of

A

Continue metfrmin if tolerated
Offer NPH insulin once or twice daily, consider offering short actin insulin also or biphasic esp if HbA1c >75

21
Q

When consider offering biphasic preps containing short acting insulin

A

Prefers injecting immerdiately before a meal
Hypoglycaemic
Blood glucose levels markedly raised after meals

22
Cause of diabetes
Decreased beta cell function and insulin function in muscle and liver
23
What is importnat to also consider in diabetes
Lipid levels and Qrisk score, other cardiac risk factors and how to control them Weight loss, education about remission
24
Mechanism of action of metformin
Reduced hepatic glucose output Increased insulin sensitivity
25
What diabetic medication can help weight loss?
Metformin GLP-1 analogues nad DPP4-inhibitors SGLT2 inhibitors
26
Side effects of metformin
GI upset - try modified release and start on low dose, titrate up RARE - lactic acidosis
27
MOA of DPP4 inhibitors
sTOP glp-1 BREAKDOwn, increase GLP-1 to act on beta cells in pancreas to increase insulin release Incretin based
28
Examples of SGLT2 inhibitors
Dapagliflozin, canagliflozin, empagliflozin
29
MOA of SGLT2 inhibitors
Block reabsorption of glucose at proximal tubule - increase excretion in urine
30
Side effect of SGLT2 inhibitors
UTI due to increase glucose in urine
31
What extra benefits do SGLT2 inhibtiors have
Cardiovascular risk reduction, reduced HF hosptialisation
32
MOA of sulfonylureas
Stimulates insulin secretion from beta cells V fast onset - fast reduction of glucose
33
Negative of sulonylureas
Weight gain cause hypos because of speed
34
Piaglitazone MOA
Improves tissue sensitivity to insulin
35
Porblems with piaglitazone
Fluid retnetion Weight gain HF - increased straing on the heart esp if preexisitng conditions
36
GLP 1 advantages
Weight reduction, CVS risk reduction (Semaglutide, dulaglutide, liraglutide) Less hypoglycaemia when used on own than dual therapy but as effective - occupational beenfits eg drivers Semaglutide can be taken orally GI side effects
37
What diabetic drugs reduce cardiac risk
SGLT2 inhibtors and GLP-1 analogues
38
Daily vs weekly GLP-1 analogues
Liraglutide (once), exenatide (twice) = daily Exenatice LAR, dulaglutide, semalgutide - once a week injection
39
Advantages of insulin
Direct effect on blood glucose Improves glycaemic control
40
Drawbacks of insulin
Hypo riskk Weight gain Occupational concerns INjection
41
Intermediate acting insulins
NPH insulin - insulatard, humilin I
42
Long acting insulins
Glargine, degludec
43
Short acting insulins
Actrapid, insulin aspart, inulin lispro
44
Mixed insulins
Novomix 30 (30% short acting) Humulag mix 25 (25% SA)